Page last updated: 2024-12-08
manganese phosphate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
manganese phosphate: a reddish-white fine crystalline powder relatively insoluble in water [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6452420 |
MeSH ID | M0360171 |
Synonyms (21)
Synonym |
---|
einecs 257-147-0 |
manganese hydrogen phosphate |
ec 257-147-0 |
51349-94-1 |
hureaulite |
manganese phosphate |
7782-76-5 |
manganese phosphate, dibasic |
manganum phosphoricum |
vz3u1h7q5b , |
unii-vz3u1h7q5b |
manganese phosphate dibasic [who-dd] |
manganese phosphate, dibasic [mi] |
manganum phosphoricum [hpus] |
manganese phosphate dibasic |
DTXSID40872546 |
dibasicmanganese phosphate |
Q4138145 |
manganese hydrogenephosphate |
hydrogen phosphate;manganese(2+) |
manganese(ii) hydrogen phosphate |
Research Excerpts
Toxicity
Excerpt | Reference | Relevance |
---|---|---|
"The use of the additive methylcyclopentadienyl manganese tricarbonyl in unleaded gasoline has resulted in increased attention to the potential toxic effects of manganese (Mn)." | ( Assessment of bioaccumulation and neurotoxicity in rats with portacaval anastomosis and exposed to manganese phosphate: a pilot study. Butterworth, RF; Carrier, G; Hazell, A; Kennedy, G; Mergler, D; Normandin, L; Philippe, S; Salehi, F; Therrien, G; Zayed, J, 2001) | 0.31 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (24)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (50.00) | 29.6817 |
2010's | 7 (29.17) | 24.3611 |
2020's | 5 (20.83) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 25 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |